Pegasus Biologics
Pegasus Biologics manufactures and markets bioimplants for soft tissue repair and wound care, serving various medical fields.
Founded
2003Pegasus Biologics manufactures and markets bioimplants for soft tissue repair and wound care, serving various medical fields.
Founded with a mission to advance medical treatments, Pegasus Biologics specializes in manufacturing and marketing bioimplants for soft tissue repair and wound care. Their core products include the OrthADAPT Bioimplant, designed for the repair and reinforcement of tendons and ligaments, and the Unite Biomatrix, an enzyme-resistant collagen scaffold for suture retention and intrinsic strength. The company primarily serves the orthopedics, sports medicine, and neurosurgery markets, focusing on improving patient outcomes in these specialized fields.
Pegasus Biologics has garnered attention for its innovative approach to bioimplant technology. Notable affiliated individuals include leading researchers and medical professionals who contribute to the company's R&D efforts. The company has achieved significant milestones in product development, including FDA approvals and successful clinical trials. Its impact is evident in the enhanced recovery and quality of life for patients undergoing soft tissue repair procedures.
Companies similar to Pegasus Biologics include Bone Biologics, Colorado Therapeutics, Miach Orthopaedics and MiMedx Group.
Pegasus Biologics was founded in 2003.
Pegasus Biologics' headquarters is located in Irvine, CA, US.
Pegasus Biologics' most recent funding round was for $1M (USD) in June 2009.
As of Jun 6, 2009, Pegasus Biologics has disclosed funding of $32.7M (USD). Undisclosed round amounts are excluded.
Pegasus Biologics has 75 employees as of Feb 5, 2024.
MiMedx Group
mimedx.com
